type 2 diabetes. Type 2 diabetes
Conditions
Interventions
Aerobic training (type 2 diabetes): Aerobic exercise between 25-60 minute with 50-60% of maximum oxygen consumption, 5 times per week for 8 weeks. Intervention 2: Intervention group 2
Aerobic training + Vitamin D supplementation (type 2 diabetes): Aerobic exercise between 25-60 minute with 50-60% of maximum oxygen consumption, 5 times per week for 8 weeks
5000 IU. Intervention 3: Intervention group 3
Vitamin D supplementation (type 2 diabetes): 5000 IU vitamin D supplementation per week for 8 weeks. Intervention 4: Intervention group 4
Aerobic training (obese without diabetes): Aerobic exercise between 25-60 minute with 50-60% of maximum oxygen consumption, 5 times per week for 8 weeks. Intervention 5: Intervention group 5
Aerobic training + Vitamin D supplementation (obese without diabetes): Aerobic exercise between 25-60 minute with 50-60% of maximum oxygen consumption, 5 times per week for 8 weeks
5000 IU. Intervention 6: Intervention group 6
Vitamin D supplementation (obese without diabetes): 5000 IU vitamin D supplementation per week for 8 weeks. Intervention 7: Control group 1
Control (type 2 diabetes): 8 weeks of receiving placebo, without aerobic exercise. Intervention 8: Control group 2
Control (obese without diabetes): 8 weeks of receiving placebo, without aerobic exercise. Intervention 9: Sham group: Being on treadmill without doing exercise.
Sponsors
Razi University of Kermanshah
Eligibility
Sex/Gender
Male
Age
8 Months to 9 Months
Inclusion criteria
Inclusion criteria: Age between8 to 9 months old Male sex To have type 2 diabetes in diabetic groups To have a minimum of 300 gram of weight No to have type 2 diabetes in non-diabetic obese groups
Exclusion criteria
Exclusion criteria: Movement disabilities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AMPK Gene Expression. Timepoint: Before intervention; after intervention. Method of measurement: Western-Blot method using Kiagen Kit With 0/021 Pg/mL sensitivity.;Expression Of PGC-1a Gene. Timepoint: Before intervention; after intervention. Method of measurement: Real time-PCR Method using Mirnasy mini kit50 Kit With 0/06 ng/mL sensitivity.;Expression Of PTP1B Gene. Timepoint: Before intervention; after intervention. Method of measurement: Real time-PCR Method using RNeasy Commercial Kit With 0/06 ng/mL sensitivity.;Expression Of UCP-1 Gene. Timepoint: Before intervention; after intervention. Method of measurement: Eliza Double Sandwich Method using Cat no: ZB-11252-R9648 Kit With 0/06 ng/mL sensitivity.;Insulin Resistance Index. Timepoint: Before intervention; after intervention. Method of measurement: Serum Insulin by Elisa Method using Micro-calorie Metric Kit With 5/5 mg/dl Sensitivity. Insulin Resistance Index will be Determined Using Glucose And Insulin Concentrations And HOMA-IR formula.HOMA-IR= (Glucose Concentration × Insulin Concentration)÷22/5. | — |
Secondary
| Measure | Time frame |
|---|---|
| Irisin Expression Gene. Timepoint: Before intervention; after intervention. Method of measurement: Eliza Method using EASTBIOPHARM Kit With 0/023 mg/mL sensitivity. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRastegar Hosseini
Razi University of Kermanshah
Outcome results
None listed